Suppr超能文献

分级α-葡萄糖苷酶抑制对体内糖吸收的影响。

Effects of graded alpha-glucosidase inhibition on sugar absorption in vivo.

作者信息

Madariaga H, Lee P C, Heitlinger L A, Lebenthal E

机构信息

International Institute for Infant Nutrition and Gastrointestinal Disease, Children's Hospital of Buffalo.

出版信息

Dig Dis Sci. 1988 Aug;33(8):1020-4. doi: 10.1007/BF01536000.

Abstract

The effect of inhibition of disaccharidases on the degree of absorption of glucose, lactose, and sucrose was examined utilizing an in vivo model in the rat. Acarbose, a competitive alpha-glucosidase inhibitor was utilized to selectively inhibit small intestinal mucosal enzymes. Adult rats (250-350 g body weight) were the subjects of intraduodenal bolus infusion experiments with either sugar alone or sugar plus acarbose. All sugars were infused at a dose of 0.5 g/kg body weight. Portal venous blood glucose was determined at 30-min intervals from 0 to 150 min. Glucose (monosaccharide) and lactose (beta-galactoside) absorption were not altered by the presence of acarbose. In contrast, sucrose (alpha-glucosidase) absorption was significantly diminished in the presence of acarbose. Sucrose absorption in the presence of increasing acarbose doses (0.7-5.6 mg/kg body weight) was depressed in a dose-dependent fashion. Linear regression analysis revealed a high degree of correlation between residual sucrase activity and area under blood glucose curve (r = 0.9837). Similar degrees of correlation were found between acarbose dose and area under blood glucose curve (r = -0.9322), and between residual sucrase activity and acarbose dose (r = -0.9695). These data confirm that acarbose is a selective alpha-glucosidase inhibitor that does not affect monosaccharidase transport. In the presence of acarbose, alpha-glucosidase absorption is diminished in a dose-dependent fashion. Postprandial glucose rise following an alpha-glucosidase meal seems to be determined, in the presence of graded acarbose inhibition, by residual mucosal alpha-glucosidase activity.

摘要

利用大鼠体内模型,研究了双糖酶抑制对葡萄糖、乳糖和蔗糖吸收程度的影响。使用阿卡波糖(一种竞争性α-葡萄糖苷酶抑制剂)选择性抑制小肠黏膜酶。成年大鼠(体重250 - 350克)作为十二指肠推注输注实验的对象,分别单独输注糖或糖加阿卡波糖。所有糖均以0.5克/千克体重的剂量输注。在0至150分钟内,每隔30分钟测定门静脉血糖。阿卡波糖的存在并未改变葡萄糖(单糖)和乳糖(β-半乳糖苷)的吸收。相比之下,阿卡波糖存在时蔗糖(α-葡萄糖苷酶)的吸收显著减少。随着阿卡波糖剂量增加(0.7 - 5.6毫克/千克体重),蔗糖吸收呈剂量依赖性降低。线性回归分析显示,残余蔗糖酶活性与血糖曲线下面积之间存在高度相关性(r = 0.9837)。在阿卡波糖剂量与血糖曲线下面积之间(r = -0.9322),以及残余蔗糖酶活性与阿卡波糖剂量之间(r = -0.9695)也发现了相似程度的相关性。这些数据证实阿卡波糖是一种选择性α-葡萄糖苷酶抑制剂,不影响单糖酶转运。在阿卡波糖存在的情况下,α-葡萄糖苷酶的吸收呈剂量依赖性减少。在阿卡波糖分级抑制存在的情况下,餐后α-葡萄糖苷酶餐引起的血糖升高似乎由残余黏膜α-葡萄糖苷酶活性决定。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验